What is the Typical Duration of a Mental Health Rehab Program?

When life throws challenges our way, we all react differently. Some of us might feel sad or worried, while others may show their stress through changes in behavior. Adjustment disorder is a condition that happens when someone has trouble coping with a stressful life event. When this struggle shows up mainly as problematic behaviors rather than just feelings, doctors call it adjustment disorder with disturbance of conduct.

This article will help you understand this condition, how to recognize it, and what help is available. Amae Health has been working with patients nationwide for many years, and we know better than anyone how to convey information in simple, understandable language.

Understanding Adjustment Disorder

Adjustment disorder is a mental health condition that develops when someone has difficulty coping with a stressful event or life change. These difficulties start within three months of the stressful event and don't last longer than six months after the stress has ended.

How strongly it affects your life makes this condition different from everyday stress. The emotional or behavioral symptoms are more severe than expected and can seriously impact your daily activities, work, relationships, or school performance.

There are several types of adjustment disorders, depending on the main symptoms:

• With a depressed mood (mainly feeling sad)
• With anxiety (mainly feeling nervous)
• With mixed anxiety and depression (both feelings together)
• With disturbance of conduct (mainly behavioral problems)
• With mixed disturbance of emotions and conduct (both feelings and behaviors)

What Does "Disturbance of Conduct" Mean?

When doctors talk about adjustment disorder with disturbance of conduct, they're referring to a specific way that stress shows up in a person's behavior. Unlike other types of adjustment disorder, where feelings like sadness or worry are the main symptoms, this subtype is recognized by changes in how someone acts.

"Conduct" in this context means behavior that affects others or breaks social rules. A disturbance of conduct involves acting out in ways that might violate the rights of others or go against major age-appropriate social norms or rules.

It doesn't mean the person is "bad" or deliberately causing problems. These behaviors are symptoms of difficulty adjusting to stress, just as fever is a symptom of infection, not a sick person's choice.

Common Signs and Symptoms

Key Behavioral Signs

People with adjustment disorder with disturbance of conduct typically show changes in their behavior rather than just in their mood. These changes usually start within three months of a stressful event.

Common behavioral signs include:

• Acting aggressively toward people, animals, or property
• Breaking rules at home, school, or work that they used to follow
• Arguing more frequently with family members, teachers, or supervisors
• Skipping school or work
• Ignoring previously respected boundaries
• Taking risks they wouldn't normally take
• Stealing or damaging property
• Having sudden outbursts of anger that seem out of proportion
• Deliberately annoying others
• Refusing to comply with reasonable requests

Impact on Daily Life

Adjustment disorder symptoms can significantly affect many areas of a person's life:

• Relationships: The behavioral changes can strain relationships with family members, friends, romantic partners, and colleagues. Arguments may increase, and others might start avoiding the person because of their unpredictable behavior.
• School or Work: Performance often suffers as the person may skip classes or shifts, have trouble concentrating, or get into conflicts with teachers, classmates, or coworkers. Grades might drop, or work quality may decline.
• Legal Consequences: Some behaviors associated with disturbance of conduct might lead to legal problems, especially if they involve breaking laws, damaging property, or aggressive actions.
• Self-Esteem: As problems mount in different areas of life, the person might feel worse about themselves, creating a cycle where stress leads to problematic behavior, which creates more stress.
• Physical Health: The ongoing stress and behavioral issues can affect physical health, leading to problems like headaches, stomach troubles, or sleep difficulties.

It's important to remember that these impacts aren't happening because the person chooses to be difficult. They're struggling with a genuine adjustment problem that needs understanding and proper support.

Causes and Triggers

Adjustment disorder with disturbance of conduct doesn't have a single cause. Instead, it develops from a combination of factors:

Stressful Life Events. The most obvious trigger is exposure to a stressful situation or significant life change. It might be:

• A major loss (death of a loved one, divorce, job loss)
• A significant transition (moving, changing schools, retirement)
• A sudden change in health (diagnosis of a serious illness)
• Family conflicts or domestic problems
• Financial hardships
• Workplace stress or academic pressure

Personal Vulnerability. Not everyone who faces these stressors will develop an adjustment disorder. Personal factors that might increase risk include:

• Previous mental health challenges
• Childhood experiences of trauma or instability
• Limited coping skills
• Lack of strong support systems
• Certain personality traits

Environmental Factors. The context in which the stress occurs matters too:

• Cultural factors affecting how stress is perceived and handled
• Availability of social support
• Concurrent stressors happen at the same time.
• Economic resources available to cope with challenges

Diagnosis and Assessment

Getting an accurate diagnosis of adjustment disorder with disturbance of conduct involves a thorough evaluation by a mental health professional, typically a psychiatrist, psychologist, or clinical social worker.

The Assessment Process:

• Clinical Interview: The professional will talk with you about your symptoms, when they started, recent life events, and how your functioning has changed.
• Medical History: A review of your physical health and any medications you take helps rule out medical causes for behavioral changes.
• Psychological Evaluation: You might complete questionnaires or assessments to measure your symptoms and their severity.
• Collateral Information: With your permission, the clinician might speak with family members, teachers, or others who have observed your behavior changes.
• Differential Diagnosis: The clinician will consider whether your symptoms better match other conditions.

Treatment and Management

Therapy Options

The good news about adjustment disorder with disturbance of conduct is that it responds well to treatment, especially when started early. Amae Health offers some main treatment approaches:

Cognitive-Behavioral Therapy (CBT): This approach helps identify and change unhelpful thought patterns contributing to behavioral problems. CBT teaches specific skills for:

• Managing anger appropriately
• Solving problems more effectively
• Communicating needs without aggression
• Recognizing triggers for disruptive behavior

Individual Psychotherapy: Regular sessions with a therapist provide a safe space to process feelings about the stressful event and learn healthier coping strategies.

Family Therapy: Since disturbance of conduct affects relationships, involving family members can be beneficial. Family therapy can:

• Improve communication patterns
• Help family members respond effectively to problematic behaviors
• Address family dynamics that might be maintaining the problem
• Teach everyone skills to support recovery

Group Therapy: Meeting with others facing similar challenges can reduce feelings of isolation and provide opportunities to practice new social skills.

Medication: While medications aren't usually the first treatment for adjustment disorder, in some cases, they might be prescribed to address specific symptoms like severe anxiety, insomnia, or impulsivity.

Supporting Long-Term Recovery

Beyond formal treatment, several strategies support ongoing recovery:

• Stress Management: Learning and practicing stress reduction techniques like deep breathing, progressive muscle relaxation, or mindfulness meditation.
• Lifestyle Adjustments: Regular physical activity, adequate sleep, and a healthy diet can improve mood regulation and reduce stress.
• Building Support Networks: Strengthening connections with supportive friends and family members provides emotional resources during difficult times.
• Developing Coping Skills: Working on problem-solving abilities, emotional awareness, and communication skills creates resilience for future challenges.
• Environmental Changes: When possible, modifying or removing ongoing sources of stress can reduce symptoms.

When to Seek Help

It's essential to reach out for professional help if you notice these signs in yourself or someone you care about:

• Behavioral changes that persist for several weeks after a stressful event
• Actions that are causing problems at school, work, or in relationships
• Aggressive behavior that could harm the person or others
• Declining performance at school or work
• Withdrawing from previously enjoyed activities
• Getting into legal trouble
• Using alcohol or drugs to cope with stress
• Expressing hopelessness or having thoughts of self-harm
• Behavioral problems that don't improve despite your best efforts to help

Early intervention for adjustment disorder with disturbance of conduct can prevent symptoms from worsening and reduce the risk of long-term consequences. Remember that seeking help is a sign of strength, not weakness.

How Amae Health Can Help

At Amae Health, we understand that facing an adjustment disorder can be challenging, but you don't have to go through it alone. Our compassionate team specializes in supporting people through difficult life transitions.

Our approach to treating adjustment disorder with disturbance of conduct is personalized, comprehensive, and evidence-based. We offer:

• Expert assessment and diagnosis by experienced mental health professionals
• Individual therapy using proven approaches like Cognitive-Behavioral Therapy
• Family therapy to strengthen your support system
• Skills-based groups focused on anger management and stress reduction
• Coordination with schools or workplaces when helpful
• A warm, welcoming environment where you'll feel understood and respected

Our goal is to help reduce symptoms and empower you with tools and strategies that will serve you long after treatment ends. We believe in building resilience to help you navigate future challenges more effectively.

Frequently Asked Questions

What is the difference between adjustment disorder with disturbance of conduct and conduct disorder?

A specific stressful event triggers adjustment disorder with disturbance of conduct and typically lasts less than 6 months. Conduct disorder isn't linked to a specific stressor, develops more gradually, and tends to persist much longer with more serious violations of others' rights.

How long does adjustment disorder with disturbance of conduct last?

Adjustment disorder symptoms typically resolve within 6 months after the stressful situation ends. With proper treatment, many people see improvement much sooner.

Can this condition resolve without treatment?

Mild cases of adjustment disorder may improve independently, especially with good social support and after the stressful situation resolves. Professional help can speed recovery and prevent complications.

What are the most effective treatments for this subtype?

Cognitive-behavioral therapy and psychotherapy focusing on coping skills and addressing problematic behaviors are most effective. Family involvement in treatment often improves outcomes, especially for children and teens.

Is medication necessary for managing conduct-related symptoms?

Medication is not usually the first-line treatment, but might be prescribed temporarily in some cases. It's typically only considered for specific symptoms like severe anxiety or sleep problems.

When should someone seek professional help?

Professional help should be sought when behavioral changes after a stressful event interfere with daily functioning or cause relationship problems.

Can adults also experience adjustment disorder with disturbance of conduct?

Yes, adults can experience adjustment disorder with disturbance of conduct. In adults, the symptoms might appear as workplace conflicts, reckless behavior, or legal problems that weren't present before the stressful event.

Is this condition considered a mental illness or behavioral issue?

Adjustment disorder with disturbance of conduct is classified as a temporary mental health condition that affects behavior in response to stress. With proper support, most people return to their usual functioning without long-term mental health concerns.

‍

Maybe a genetic report flagged it. Maybe a friend, a forum, or a supplement ad told you it could explain your fatigue, your depression, or why medication never quite worked. Now you're wondering what an MTHFR gene mutation actually means for you.

MTHFR variants are extremely common. Most people who carry them have no health effects at all, and research linking them to mental health conditions shows a real but small association, not a cause. Medical experts don't recommend routine testing for them.

What the MTHFR gene does

The MTHFR gene carries instructions for an enzyme called methylenetetrahydrofolate reductase. That enzyme converts folate, a B vitamin, into the active form your body uses to turn the amino acid homocysteine into methionine. According to MedlinePlus Genetics, the active form, 5-methyltetrahydrofolate, is the main form of folate found in blood.

When the enzyme works less efficiently, homocysteine can build up. That's the mechanism behind most of the interest in MTHFR, including the mental health questions.

C677T, A1298C, heterozygous, and homozygous

Most people searching "MTHFR gene mutation" are really asking about two common variants:

• C677T. The most common and best studied. At position 677 in the gene, the DNA base C is replaced by T. The resulting enzyme is less stable and less active, especially in people with two copies.
• A1298C. The second common variant. The CDC notes there isn't enough evidence that A1298C on its own significantly affects how the body processes folate.

You inherit one copy of the gene from each parent, which is where the lab terms come from:

• Heterozygous means one copy carries the variant (for C677T, written CT).
• Homozygous means both copies carry it (TT).
• Compound heterozygous means one copy of C677T and one copy of A1298C.

These variants are so common they're closer to normal human variation than to a disease. The CDC reports that more people in the U.S. have one or two copies of C677T than don't. Having both copies is less common: MedlinePlus estimates about 25% of Hispanic people and 10% to 15% of North American white people carry two copies of C677T.

MTHFR symptoms: what the variant does and doesn't cause

Most people with common MTHFR variants have no symptoms. Cleveland Clinic puts it plainly: MTHFR gene variants most often don't affect your health or cause symptoms. When they do matter, it's usually through higher homocysteine or lower folate, and mostly in people with two copies of C677T. Even then, how much folate you get from food matters more than your genotype.

That's different from what you'll read on many wellness sites, which attribute everything from fatigue to brain fog to MTHFR. There's no reliable evidence for a list of "MTHFR symptoms" in people with the common variants. If you have symptoms, they deserve an evaluation, not an assumption that a gene variant explains them.

There is one important exception. Rare, severe mutations in the MTHFR gene cause homocystinuria, a serious inherited condition whose symptoms usually appear early in life. Most U.S. newborns are screened for it shortly after birth. That's a different situation from the common C677T and A1298C variants.

MTHFR and mental health: what research shows

Because MTHFR sits in the folate and methylation pathway, researchers have looked hard for links to psychiatric conditions. The findings are consistent in one way: the effect is modest.

• Depression. A 2013 meta-analysis of 26 studies, with 4,992 people with depression and 17,082 controls, found that two copies of C677T were associated with higher odds of depression (odds ratio 1.42). The link was stronger in Asian populations, marginal in white populations, and absent in older adults.
• Schizophrenia, bipolar disorder, and depression combined. A 2011 meta-analysis of case-control studies with 29,502 participants found TT carriers had modestly higher odds of these conditions as a group (odds ratio 1.26). The authors read this as evidence of a shared genetic vulnerability across the three conditions.

An odds ratio of 1.26 to 1.42 is a small increase in relative risk for a very common genotype. Most people with two copies of C677T never develop depression, bipolar disorder, or schizophrenia, and most people with those conditions don't have two copies. Mental health conditions come from many genes and life experiences acting together. MTHFR is, at most, one small piece.

Folate, folic acid, and methylfolate

A common online claim is that people with MTHFR variants can't use folic acid and need "methylated" supplements instead. The CDC says that isn't true: people with an MTHFR variant can process all types of folate, including folic acid. People with the TT genotype have blood folate levels only about 16% lower on average than people with CC at the same intake, and folic acid intake matters more than genotype in determining blood folate.

L-methylfolate, the active form, has been studied as an add-on to antidepressants. In two randomized trials published in the American Journal of Psychiatry in 2012, adults with depression that hadn't responded fully to an SSRI received L-methylfolate or placebo alongside their medication. The first trial, with 148 patients starting at 7.5 mg a day, found no difference. The second, with 75 patients at 15 mg a day, found a significant benefit over placebo. Both enrolled people based on their depression, not on a genetic test. Whether any add-on makes sense for a specific person is a clinical decision that depends on their full history.

For more on how folate and other nutrients relate to mood, see our article on nutrient deficiencies and anxiety.

Should you get tested for MTHFR?

For most people, no. MedlinePlus states that medical experts don't recommend testing for common MTHFR gene changes in most cases. A provider may order it in specific situations, such as high homocysteine on a blood test combined with a family history.

The American College of Medical Genetics and Genomics went further in a 2013 practice guideline: MTHFR polymorphism testing has minimal clinical utility and shouldn't be part of a routine evaluation for blood clotting disorders. Recent meta-analyses had disproven the links that originally motivated the testing.

If you already have a result, it's still useful context to share with your care team. It just isn't a diagnosis, and it isn't a treatment plan.

When depression or mood symptoms don't improve

People often look up MTHFR because something isn't working: depression that keeps coming back, medication that only half helps, or mood swings no one has explained. Those problems are real, even if MTHFR is unlikely to be the answer. They usually call for a fuller psychiatric evaluation: a closer look at the diagnosis, past medication trials, co-occurring conditions, sleep, substance use, and physical health.

That's the kind of care we provide at Amae Health. Our clinics specialize in conditions including Major Depressive Disorder, bipolar disorder, and schizophrenia. Our care teams bring psychiatrists, therapists, primary care physicians, and dietitians under one roof, so lab results, nutrition, and medication history are reviewed together, by people who share one treatment plan. See how our integrated outpatient clinics work.

Frequently asked questions

How common is the MTHFR gene mutation?

Very common. According to the CDC, more people in the U.S. have one or two copies of the C677T variant than don't. Two copies are less common, estimated at about 25% of Hispanic people and 10% to 15% of North American white people.

What are the symptoms of being MTHFR C677T heterozygous?

Usually none. According to MedlinePlus, raised homocysteine is seen mainly in people with two copies of C677T. If you have symptoms, they need an evaluation of their own rather than being attributed to one copy of a common variant.

Does MTHFR cause depression?

No single gene causes depression. Two copies of C677T are associated with modestly higher odds of depression in meta-analyses, with an odds ratio around 1.4, but most people who carry them never develop depression.

Do people with MTHFR need methylfolate instead of folic acid?

According to the CDC, no. People with MTHFR variants can process folic acid, and folic acid intake matters more than genotype for blood folate levels. L-methylfolate has been studied as an add-on treatment for depression, regardless of MTHFR status, and decisions about it belong with a clinician.

Is MTHFR testing worth it?

For most people, it isn't recommended. Medical genetics experts say the common variants have minimal clinical utility. A provider may order testing in specific cases, such as unexplained high homocysteine with a family history.

Key takeaways

• An MTHFR gene mutation usually means one or two copies of the common C677T or A1298C variants, which most people carry without health effects.
• Two copies of C677T can raise homocysteine and are linked to modestly higher odds of depression, bipolar disorder, and schizophrenia, but the effect is small.
• People with MTHFR variants can process folic acid, and routine MTHFR testing isn't recommended.
• If depression or mood symptoms aren't improving, a full psychiatric evaluation is more useful than a gene result.

If you or someone you love is living with depression, bipolar disorder, or schizophrenia that hasn't responded to treatment, request an intake appointment. Our team will walk you through how an evaluation works and what to bring, including any lab or genetic results you already have.

Most people comparing TMS vs medication for depression arrive at the question the same way: the antidepressants have not brought enough relief. If that is you, it helps to know that both are evidence-based, FDA-cleared treatments, and they work in completely different ways. Medication adjusts brain chemistry from the inside. TMS stimulates the brain directly with magnetic pulses. Neither is universally better. The right choice depends on your treatment history, the severity of your symptoms, how you tolerate side effects, and your own preferences, especially once you are dealing with treatment-resistant depression or trying to figure out what to do when antidepressants don't work. This article compares the two fairly, not to push one over the other.

How Antidepressants Work

Antidepressants change the availability of certain brain chemicals, mainly serotonin and norepinephrine, that influence mood. The most common are SSRIs (selective serotonin reuptake inhibitors) and SNRIs (serotonin-norepinephrine reuptake inhibitors). Both are considered first-line treatment, meaning they are usually where a clinician starts.

‍

They are taken daily as a pill at home, and they work gradually. Most people need several weeks before the full effect shows, which is one of the harder parts of starting an antidepressant: you often have to wait to know whether it is working. Finding the right medication and dose regularly takes some trial and adjustment, and a first medication that does not help does not mean none will. There are many options within each class, so a clinician can switch or fine-tune based on how a person responds. Older tricyclic antidepressants (TCAs) also work but tend to cause harsher side effects, so they are usually reserved for later steps rather than first-line use. The main appeal of medication is convenience and evidence: it is taken at home, it is inexpensive, and it has decades of research behind it.

How TMS Works

Transcranial magnetic stimulation (TMS) is a non-invasive treatment that uses focused magnetic pulses, similar in strength to an MRI, to stimulate the mood-regulating areas of the brain that tend to be underactive in depression, mainly the left dorsolateral prefrontal cortex. It is FDA-cleared for major depressive disorder in adults, and also for OCD (NIMH, Brain Stimulation Therapies).

‍

TMS is not electroconvulsive therapy (ECT). There is no anesthesia and no sedation, and the patient stays fully awake through each session, then drives home and returns to normal activity. During a session, a coil rests against the scalp and delivers pulses in short cycles, which most people feel as a tapping sensation. A typical course runs about five days a week for several weeks, with each session lasting under an hour, and the benefit tends to build gradually across the course rather than after any single visit.

‍

As a non-drug option, TMS is one of the main alternatives to antidepressants for people whose medication has stopped short. It usually works best as part of a broader treatment plan, coordinated with therapy and, in many cases, ongoing medication, rather than as a replacement for all other care.

TMS vs Medication: Side-by-Side Comparison

The two treatments differ on almost every practical dimension, from how they are delivered to how quickly they work and what they ask of you day to day. The table below lays the key differences side by side, and the sections that follow unpack the two that matter most to people making this decision: side effects and success rates.

Side Effects Compared

Antidepressant side effects vary by class. SSRIs commonly cause weight gain and sexual dysfunction, though some effects ease after the first few weeks. SNRIs have a similar profile that is often milder. TCAs tend to be harsher, which is why they are rarely a first choice. These are systemic effects, because the medication acts throughout the body.

‍

TMS side effects are usually mild and short-lived: scalp discomfort, headache, or lightheadedness that typically passes soon after a session and lessens over the first week. The most serious risk, seizure, is very rare. Because TMS is non-invasive and targeted rather than systemic, it avoids the weight, sexual, and sleep side effects associated with medication, and it does not affect memory or cognition the way some people fear based on older brain treatments like ECT.

‍

It is not side-effect-free, though, and its main practical downside is different in kind. Instead of a daily side effect, TMS asks for a time commitment: traveling to a clinic most weekdays for several weeks. For someone with a demanding schedule or limited transportation, that logistical cost is real and worth weighing against the appeal of avoiding medication side effects. Neither profile is automatically easier to live with; they are simply different, and which one fits depends on the person.

Success Rates: What the Research Shows

Both treatments help many people, and neither helps everyone. Reading the numbers honestly matters more than cheerleading for either one. Two terms come up often: response means a meaningful reduction in symptoms, usually cutting them roughly in half, while remission means symptoms largely resolve. Remission is the higher bar and the real goal.

‍

For medication, the landmark STAR*D study found that roughly a third of patients reached remission on their first SSRI (Trivedi et al., American Journal of Psychiatry, 2006). That is a genuinely useful result for many people. But it also means most did not remit on the first try, and STAR*D showed that with each additional medication tried after a failure, the odds of remission tend to drop while side-effect burden tends to rise. That diminishing return is exactly the situation that leads people to look at other options.

‍

For TMS, a large real-world registry of more than 5,000 patients found that most experienced measurable improvement, with response rates ranging from about 58% to 83% and remission from about 28% to 62%, depending on how outcomes were measured (Sackeim et al., Journal of Affective Disorders, 2020). The wide ranges are worth noting: they reflect different rating scales and patient groups, and many of those patients were also taking medication, so the numbers describe TMS in real-world use rather than in isolation.

‍

For treatment-resistant depression specifically, a 2024 randomized trial compared TMS with switching or augmenting medication in 89 people who had not responded to at least two antidepressants, with both groups also receiving psychotherapy. The TMS group had significantly higher response and remission rates than the medication group (Dalhuisen et al., American Journal of Psychiatry, 2024). It is one of the clearest head-to-head comparisons available, though individual results always vary, and these figures describe groups, not guarantees for any one person.

When Antidepressants Don't Work: Where TMS Fits

About a third of people with major depressive disorder do not respond adequately to first-line treatment, a pattern clinicians call treatment-resistant depression. It is not a sign of personal failure or a rare edge case; it is common, and it has its own growing set of treatment options. When two or more medications have failed, or when side effects are intolerable, TMS becomes a well-supported next step, and the 2024 trial above is part of why it is increasingly positioned early in the treatment-resistant pathway rather than as a last resort.

‍

TMS is not the only option at this stage. Spravato (esketamine), a nasal spray derived from ketamine, is FDA-approved for treatment-resistant depression when used together with an oral antidepressant. It is given in a certified clinic under medical supervision, with monitoring after each dose, because of its dissociative effects. Combining TMS with an antidepressant is another route, and research suggests the combination can improve outcomes over medication alone. The larger point is that once first-line medication falls short, the path forward branches into several evidence-based options, and those branches are not mutually exclusive. A person might use medication and TMS together, or move from one approach to another as their psychiatrist learns what their brain responds to.

Who Is Each Treatment For?

Medication is often the right starting point for someone who is:

‍

• Early in treatment for depression
• Managing mild to moderate symptoms
• Looking to avoid in-clinic visits
• Someone who has responded well to an antidepressant before

‍

TMS is generally considered for someone who:

‍

• Has tried multiple antidepressants without adequate relief
• Cannot tolerate medication side effects
• Prefers a non-drug approach
• Has treatment-resistant depression

‍

Many people use both at different points, and some use them together. Where a person lands is a clinical decision, not a solo consumer choice, and it belongs with a psychiatrist who knows the full history.

Making the Decision With a Psychiatrist

TMS, medication, Spravato, and therapy are not competing products. They are tools a psychiatrist combines and adjusts based on diagnosis, history, and how a person responds over time. Comparing TMS and medication on paper is useful, but the decision is rarely either-or, and it is rarely one-and-done. It usually looks more like a sequence: start somewhere reasonable, measure the response, and adjust. The most reliable way to navigate that sequence, and to change course when needed, is a thorough evaluation within an integrated care setting, where the clinician managing your medication is the same one weighing whether TMS or another option fits.

‍

That is how care works at Amae Health. Our psychiatry-led teams evaluate the whole picture and coordinate treatment across medication, therapy, and procedures like TMS, which we offer at our Los Angeles clinic. You can explore our full range of treatments or, for severe depression that needs more structure, our Partial Hospitalization Program. Our resources for patients and families explain how integrated care works, and you can contact our team to ask about an evaluation.

Frequently Asked Questions

Is TMS better than medication for depression? Neither is universally better. Medication is first-line and works well for many people. For treatment-resistant depression, where two or more medications have failed, TMS often outperforms a medication switch. The right choice depends on history, severity, and side-effect tolerance.

‍

Can you do TMS and take antidepressants at the same time? Yes. TMS can be combined with antidepressants, and research suggests the combination can improve outcomes compared with medication alone. This should be coordinated by a psychiatrist.

‍

What are the side effects of TMS vs medication? TMS side effects are usually mild and short-lived, mainly scalp discomfort or headache that fades after the first week. Medication side effects vary but can include weight change, sexual dysfunction, and fatigue. Because it is non-invasive, TMS avoids the systemic side effects of medication.

‍

Does TMS work when antidepressants don't? Often, yes. TMS is specifically supported for treatment-resistant depression. A 2024 randomized trial found higher response and remission rates with TMS than with switching medications after failed trials. Individual results vary.

‍

How long does TMS treatment take? A typical course is sessions about five days a week for several weeks, each lasting under an hour. Antidepressants, by contrast, are taken daily and may take several weeks to show their full effect.

‍

What if neither TMS nor medication works? Other options exist, including Spravato (esketamine) used with an oral antidepressant, combination approaches, and structured programs like IOP or PHP for severe depression. A psychiatrist can help identify next steps. Depression is hard, and support is available: if you are struggling, call or text the 988 Suicide and Crisis Lifeline at 988, anytime.

‍

Citations

1. Trivedi MH, Rush AJ, Wisniewski SR, et al. "Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D." American Journal of Psychiatry, 2006. psychiatryonline.org. Tier 1 (peer-reviewed).
2. Sackeim HA, Aaronson ST, Carpenter LL, et al. "Clinical outcomes in a large registry of patients with major depressive disorder treated with transcranial magnetic stimulation." Journal of Affective Disorders, 2020. sciencedirect.com. Tier 1 (peer-reviewed).
3. Dalhuisen I, van Oostrom I, Spijker J, et al. "rTMS as a Next Step in Antidepressant Nonresponders: A Randomized Comparison With Current Antidepressant Treatment Approaches." American Journal of Psychiatry, 2024. PubMed 39108161. Tier 1 (peer-reviewed RCT).
4. National Institute of Mental Health, "Brain Stimulation Therapies." nimh.nih.gov. Tier 2 (U.S. government).

‍

Further reading (external resources): NIMH, Depression; Mayo Clinic, Transcranial Magnetic Stimulation.

‍